Related Experiment Video
Updated: Jul 5, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
A potential krimpsiekte vaccine.
C J Botha1, J E Crafford, V P Butler
1Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, 0110 South Africa. christo.botha@up.ac.za
A novel vaccine targeting cotyledoside, the cause of krimpsiekte (cardiac glycoside poisoning) in livestock, successfully induced antibody production and protected sheep from poisoning. This indicates a feasible preventative strategy for this plant-induced intoxication.
Area of Science:
- Veterinary Toxicology
- Immunology
- Pharmacology
Background:
- Krimpsiekte is a significant plant-induced intoxication in South African small stock, caused by cumulative neurotoxic bufadienolides like cotyledoside.
- Cardiac glycoside poisoning poses a threat to livestock health and productivity.
Purpose of the Study:
- To synthesize a cotyledoside-bovine serum albumin conjugate for animal immunization.
- To evaluate the efficacy of this conjugate in inducing an immunological response and protecting against cotyledoside toxicity.
Main Methods:
- A cotyledoside-protein conjugate was synthesized and used to immunize rabbits and sheep.
- Enzyme-linked immunosorbent assay (ELISA) was employed to determine antibody titers against cotyledoside.
- Vaccinated sheep were challenged with intravenous cotyledoside doses to assess protection.
Main Results:
- Immunization successfully induced anticotyledoside antibodies in both rabbits and sheep.
- Vaccinated sheep showed clinical protection against repeated intravenous cotyledoside challenge, while a control animal died.
- The vaccine appears effective in preventing krimpsiekte symptoms.
Conclusions:
- Vaccination against cotyledoside is a potentially feasible method for preventing krimpsiekte in small stock.
- Further research is warranted to optimize and implement this preventative strategy.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Vaccinations
Cross-reactivity
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccine Production
CRISPR